STOCKWATCH
·
Medical Specialities
Quarterly ResultApr 30, 2026, 11:53 AM

CI Q1 Diluted EPS $6.26, up 29%; Revenue $68.49B, up 4.6%

AI Summary

The Cigna Group reported strong first-quarter 2026 results with diluted EPS increasing 29% to $6.26 and total revenues rising 4.6% to $68.49 billion. Net income attributable to shareholders grew 25% to $1.65 billion. The company repaid $550 million in senior notes and declared a quarterly dividend of $1.56 per share, while not repurchasing common stock in the quarter.

Key Highlights

  • Diluted EPS increased 29.07% to $6.26 from $4.85 YoY.
  • Total Revenues rose 4.57% to $68.49 billion from $65.50 billion YoY.
  • Shareholders' Net Income grew 25.02% to $1.65 billion from $1.32 billion YoY.
  • Income from operations increased 19.63% to $2.36 billion from $1.97 billion YoY.
  • Repaid $550 million of 1.250% senior notes that matured in March 2026.
  • Declared a Q2 cash dividend of $1.56 per share, payable June 18, 2026.
  • Net cash provided by operating activities was $1.13 billion, down from $1.92 billion YoY.
  • No common stock repurchases in Q1 2026 vs. $1.51 billion in Q1 2025.
CI
Medical Specialities
Cigna Group

Price Impact